Harness Biotech Rebrands Equine Performance Formula Amidst Blood Test Success
Louisville, KY / Vancouver, BC – April 25, 2019 – Harness Biotech is pleased to report that its patent pending 100% natural performance and recovery gel Velocity™ has been independently found risk free for all levels of competitive equine enthusiasts. The blood test was performed by Miller and Associates Veterinarians and third party testing agency Center for Tox Services.
“The results of the blood test definitively show that Velocity passes the most rigorous analysis that are used,” says Brad Dieter, PhD, who sits on Harness Biotech’s Scientific Board, “We purposefully sought out third-party testers and independent veterinarians to ensure that we had the best possible test. These results, coupled with the high regulated process our product undergoes during manufacturing, are key to showing the world the quality and integrity that Velocity brings to the world of equestrian sports.”
Initially launched during Breeders’ Cup Week under the name Harness Performance and Recovery Gel, Velocity™ is the only product of its kind; a gel that can distribute Carnosine through topical application. The clean blood test is a particularly significant triumph, as equine events are highly regulated.
Carnosine has been widely studied for its effects on improved wound healing, antioxidant activity and its anti-aging properties since the early 1900s. As the official global rights holder and licensor of the Carnosine complex, Harness Biotech is proud to be the first entity to successfully develop a topical application that directly (and almost immediately) increases levels of Carnosine in the muscle of horses.
“It is reasonable to postulate that the more carnosine in a horse’s muscles, the better it will perform,” says Dr. Warwick Bayly, a renowned Veterinarian and Professor of Equine Medicine at Washington State University, “At the racetrack even a 1% improvement is huge, that’s about 5-6 lengths over a mile, and that's often the difference between winning and losing.”
Members of the Harness science and executive team will be in Lexington, Kentucky for Keeneland’s 2019 Spring Meet on April 26.
About Harness Biotechnologies Inc.
A global innovation-driven biotechnology company dedicated to improving equine performance. Harness Biotechnology Inc. researches, licenses, develops and commercializes one-of-a-kind scientific performance and recovery treatments for the equine industry. Harness, is the official global rights holder and licensor of a patent pending one-of-a-kind 100% natural performance and recovery gels for topical application and distribution of Carnosine. Harness products are made in the USA and contain no prohibited substances.
At Harness, we put our products to the test in our barns and on our horses. We back every order with our 100% Happiness Guarantee so that you can shop with confidence. If anything you purchase fails to meet your expectations in any way, just let us know and we’ll refund your money right away. 100% Satisfaction Guaranteed!
Carnosine is a natural and valuable performance and recovery compound for competitive equine athletes, especially those who train at the highest level with high-intensity performance and recovery requirements. Equine athletes whose performances demand serious anaerobic output benefit the most from the use of Carnosine. During high-intensity exercise, acid increases and pH decreases in the muscle tissue, changing the ability of the muscles to perform. Studies have shown that Carnosine prevents the increase in acid and drop in pH, allowing a horse to perform better, for longer. Equine athletes benefit from increased Carnosine concentrations during power and recovery from the Nitric Oxide potentiating properties that it produces. Studies have shown its positive effects on improved wound healing, antioxidant activity, anti-aging properties as well as speeding up recovery time after sports, making Carnosine a valuable tool in increased performance and recovery.
# # #
Company Name: Harness Biotechnologies Inc.
Contact Person: David Davies, VP Corporate Communications
Email: Send Email
Country: United States